Dr. Reddy’s Laboratories has announced the launch of a new division called Dr. Reddy’s Trade Generics. This division will focus on marketing and distributing generic drugs directly to retailers and wholesalers.
Trade generics are drugs that bypass doctors and are marketed directly to retailers and wholesalers. They are then sold to consumers, unlike traditional marketing methods.
Dr. Reddy’s believes there is a growing market for trade generics in India. The increase in retail pharmacies and consumer awareness about the benefits of generic drugs is driving this market.
The new division will be led by Mr. Amit Aggarwal, a pharmaceutical industry veteran with over 20 years of experience. He plans to build a strong portfolio of trade generics and expand their presence throughout India.
Dr. Reddy’s strategic move to launch this division highlights its commitment to the trade generics market. With its position in the industry, the company is poised to take advantage of the market’s growth and opportunities.
